Leishmaniasis pp 891-893 | Cite as

Ribosome-Inactivating Proteins and Leishmania: New Strategies for Future Research

  • Pietro Cenini
  • Fiorenzo Stirpe
Part of the NATO ASI Series book series (NSSA, volume 171)


Few drugs are under investigation for the cure of leishmaniasis and none has so far proved to be totally satisfactory. Researchers are therefore still looking for new substances which could be employed as an-tileishmanial agents. We now draw attention to a group of proteins extracted from plants and known as ribosome-inactivating proteins (RIPs) which have recently given great interest for their wide potential uses in chemotherapy (1–5).


Cutaneous Leishmaniasis Acanthamoeba Castellanii Pokeweed Antiviral Protein Leishmania Promastigotes Antileishmanial Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    S. Olnes and A. Phil, Toxic lectins and related proteins, in: ‘Molecular action of toxins and viruses’, P. Cohen and S. van Heyningen, eds., Elsevier, Amsterdam, New York (1982).Google Scholar
  2. 2.
    L. Barbieri and F. Stirpe, Ribosome-inactivating proteins from plants: properties and possible uses, Cancer Surveys 1: 489 (1982).Google Scholar
  3. 3.
    A. Jimenez and D. Vazquez, Plant and fungal protein and glycoprotein toxin inhibiting eukaryote protein synthesis, Ann.Rev.Microbiol. 39: 649 (1985).CrossRefGoogle Scholar
  4. 4.
    F. Stirpe and L. Barbieri, Ribosome-inactivating proteins up to date, FEBS Lett. 195: 1 (1986).PubMedCrossRefGoogle Scholar
  5. 5.
    W.K. Roberts and C.P. Selitrennikoff. Plant proteins that inactivate foreign ribosomes, Biosci.Rep. 6: 19 (1986).PubMedCrossRefGoogle Scholar
  6. 6.
    Y. Endo, K. Mitsui, M. Motizuki, and K. Tsurugi, The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes, J.Biol.Chem. 262: 5908 (1987).PubMedGoogle Scholar
  7. 7.
    Y. Endo and K. Tsurugi, RNA N-glycosidase activity of ricin A-chain, J.Biol.Chem. 262: 8128 (1987).PubMedGoogle Scholar
  8. 8.
    A. Gasperi-Campani, L. Barbieri, E. Lorenzoni and F. Stirpe, Inhibition of protein synthesis by seed-extracts. A screening study, FEBS Lett. 76: 173 (1977).PubMedCrossRefGoogle Scholar
  9. 9.
    A. Gasperi-Campani, L. Barbieri, P. Morelli and F. Stirpe, Seed extracts inhibiting protein synthesis in vitro, Biochem. J. 186: 439 (1980).PubMedGoogle Scholar
  10. 10.
    A. Gasperi-Campani, L. Barbieri, M.G. Battelli and F. Stirpe, On the distribution of ribosome-inactivating proteins amongst plants, J. Nat.Prod. 48:446 (1985).CrossRefGoogle Scholar
  11. 11.
    L. Barbieri, C. Stoppa and A. Bolognesi, Large scale chromatographic purification of ribosome-inactivating proteins, J. Chromat.(in the press).Google Scholar
  12. 12.
    E.S. Vitella and J.W. Uhr, Immunotoxins, Ann.Rev.Lnnunol.3: 197 (1985).Google Scholar
  13. 13.
    A.E. Frankel, L.L. Houston, B.F. Issell and G. Fatham, Prospects for irnmunotoxin therapy in cancer, Ann.Rev.Med. 37: 125 (1986).PubMedCrossRefGoogle Scholar
  14. 14.
    W.K. Roberts and C.P. Selitrennikoff, Isolation and partial characterization of two antifungal proteins from barley, Biochem.Biophys. Acta 880: 161 (1986).PubMedCrossRefGoogle Scholar
  15. 15.
    M.D. Howell and C.L. Villemez, Toxicity of ricin, diptheria toxin and alpha-amanitin for Acanthamoeba castellanii, J.Parasitol. 70: 918 (1984).PubMedCrossRefGoogle Scholar
  16. 16.
    C.L. Villemez, M.A. Russell. L. Barbieri, F. Stirpe, J.D. Irvin and J.D. Robertus, Catalytic toxins for the preparation of protozoan irnmunotoxins, in: ‘Membrane-mediated cytotoxicity’, B. Bonavida and R.J. Collier, eds., Alan R. Liss, New York (1987).Google Scholar
  17. 17.
    T. De Barsy, P. Devos and F. van Hoof, A morphological and biochemical study on the fate of antibody-bearing liposomes, Lab.Invest. 34: 273 (1976).PubMedGoogle Scholar
  18. 18.
    G.L. Nicolson and G. Poste, Mechanism of resistance to ricin toxin in selected mouse lymphoma cell lines, J.Supramolec.Struc. 8: 235 (1978).CrossRefGoogle Scholar
  19. 19.
    D. P. Mcintosh and T. D. Heath, Liposome-mediated delivery of ribosome-inactivating proteins in vitro. Biochem. Biophy s. Acta 690: 224 (1982).CrossRefGoogle Scholar
  20. 20.
    C.L. Villemez and P.L. Carlo, Preparation of an iromunotoxin for Acanthamoeba castellanii, Biochem. Biophy s. Res. Commun. 125: 25 (1984).CrossRefGoogle Scholar
  21. 21.
    C.R. Alving, E.A. Steck, W.L. Chapman Jr., V.B. Waits, L.D. Hendricks, G.M. Swartz Jr. and W.L. Hanson, Therapy of leishmaniasis: superior efficiencies of liposome-encapsulated drugs, Proc.Natl.Aca. Sci.USA 75: 2959 (1978).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • Pietro Cenini
    • 1
  • Fiorenzo Stirpe
    • 1
  1. 1.Dipartimento di Patologia sperimentaleUniversità di BolognaBolognaItaly

Personalised recommendations